Assignee
RELAY THERAPEUTICS INC
US·14 granted patents·13 pending applications·63 citations·filing 2017–2025
Top patents by PatentIndex Score
27 records- 0196US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0291US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0388US12219327B2Substituted isoindolines as PI3K-alpha inhibitorsRELAY THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 0486US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 0585US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 0684US11529347B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Dec 20, 2022·4 cites·8 claims
- 0783US11780845B2FGFR inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Granted Oct 10, 2023·1 cites·2 claims
- 0882US11890281B2SHP2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·1 cites·27 claims
- 0981US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 1078US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 1174US12152034B2FGFR inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·1 cites·19 claims
- 1271US2024122925A1Shp2 phosphatase inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1368US2026035335A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1466US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1565US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1663US2026041669A1Solid forms of a cdk inhibitorRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1759US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1858US12581252B2Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitorsRELAY THERAPEUTICS INC·Filed 2021·Granted Mar 17, 2026·0 cites·20 claims
- 1958US2025388565A1Estrogen receptor alpha degraders and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2058US2025243204A1Fgfr inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2157US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2256US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2354US2025084048A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2454US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2552US12522605B2FGFR inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Jan 13, 2026·0 cites·20 claims
- 2649US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2740US12138263B2Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2024·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when RELAY THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →